The traditional Chinese medicine that could become ‘key treatment’ for heart attacks, as study finds it lowers inflammation without adverse effects
Astragalus root, long used in traditional Chinese medicine, has been found to reduce inflammation in a study on heart attack patients. It has an advantage over other cardiovascular medicines in that it does so without lowering patients’ immunity, something researchers say is ‘important’
Traditional Chinese medicine (TCM) derived from the root of the Astragalus herb can significantly reduce inflammation in heart attack patients and boost immunity, according to scientific research.
Researchers at Newcastle University in the UK conducted the study on older patients who were given the plant-based compound for more than a year after suffering heart attacks, alongside a group who were given a placebo.
They found that a compound extracted from Astragalus root known as TA-65 significantly reduced inflammation without negatively affecting their immune systems, unlike current cardiovascular treatments.
The study, published in the journal GeroScience, showed when TA-65 was given to patients for over a year after they suffered a heart attack, it specifically increased lymphocytes – a type of white blood cell that helps the body’s immune system.
In addition, patients treated with the drug experienced far fewer complications and issues, such as chest or joint pain, following their heart attack.
Ioakim Spyridopoulos, professor of cardiology and cardiovascular gerontology at Newcastle University, led the study, working with the heart team at The James Cook University Hospital in the nearby city of Middlesbrough.
“It has become widely recognised that inflammation plays a key role in the formation, progression, and rupture of a coronary plaque, which induces heart attack, but, importantly, it is also a major risk factor for further complications,” Spyridopoulos says.
“Reducing inflammation is, therefore, considered a key treatment target following a heart attack for patients, and our study showed that TA-65 reduced inflammation by up to 62 per cent.”
The study was carried out on 90 patients aged 65 and over. Patients had blood measurements taken at baseline, after six months, and after a year, and were reviewed regularly in the clinic to check for any side effects.
If we can show TA-65 improves outcomes of patients who have suffered a heart attack, it will become an addition to patients’ medical care Ioakim Spyridopoulos, professor of cardiology and cardiovascular gerontology at Newcastle University
“While some potent anti-inflammatory drugs have been shown to improve outcomes after heart attacks, they result in suppression of the immune system and increase the risk of severe infections,” Spyridopoulos says.
“In our study, the widely available drug TA-65 was shown to reduce inflammation but also appears to improve immunity by increasing a patient’s immune cells,” he adds.
Those who received the TA-65 drug had few adverse effects, such as a fever or new medical problem, following their heart attack and showed 30 per cent fewer adverse effects than the group given a placebo.
Spyridopoulos says: “If we can show that TA-65 improves the clinical outcomes of patients who have suffered a heart attack, on top of modern treatment options, it will become an important addition to patients’ medical care.”
The research team now hopes to conduct a larger trial focusing on whether TA-65 reduces adverse cardiac events, such as more heart attacks or even death, in such patients.
TCM has been used for thousands of years, but there is limited empirical evidence of its effects. However, it is gaining recognition, with the World Health Organization recently adding TCM therapies to its global diagnostic compendium for the first time.
TCM is believed to have a wide variety of antioxidant components which can be beneficial in treating cardiovascular disease, which mainly develops as a result of oxidative stress.
Previous studies have found that certain TCM compounds appear to have significant anti‐hypertensive effects, and can improve outcomes in coronary heart disease, heart failure and type 2 diabetes. However, the data is inconsistent because of a lack of large‐scale randomised controlled trials.
Claims have also been made that TCM can aid with quitting smoking and even boosting immunity to fight Covid-19.
Astragalus, which is available in liquid, capsule, tablet, intravenous and inhalable forms, is not recommended for pregnant women or those breastfeeding, children, or people with autoimmune disease. The side effects of taking it may include rashes, itching, nausea, diarrhoea and headaches.
Original article by admin, if reproduced, please cite the source as: https://www.tcmha.com/tcmnews/the-traditional-chinese-medicine-that-could-become-key-treatment-for-heart-attacks-as-study-finds-it-lowers-inflammation-without-adverse-effects.html
相关推荐
-
China’s Ginseng Industry: Key ingredient in Traditional Chinese Medicine gets development boost
In the past couple of years, the city of Tonghua has been upgrading the ginseng industrial structure. Raw ginseng farming and trade – the centuries-old practices – were gradually replaced with ginseng processing and marketing. The city has developed many ginseng cosmetics and health supplements brands of its own.
-
Traditional Chinese winter medicine is just the tonic
Traditional Chinese medicine plays an important role in disease prevention, treatment and control. It can not only treat diseases but also work as a tonic. It even assists the treatment for coronavirus and has a positive function while coordinated with Western medicine. Gaofang With the onset of winter, it is the season to take gaofang. According to traditional Chinese medicine concepts, taking gaofang can enhance health, especially for those with weak immunity and chronic diseases. Tuesday is marked as dongzhi, or winter solstice, under the Chinese lunar calendar. It is…
-
Experts urge rapid digitalization of TCM to reap full benefits
Traditional Chinese medicine is expected to play a bigger role in protecting Chinese people’s health, with the top leadership determined to promote its development, according to experts and practitioners.
-
Cameroon medical workers get TCM training
When Cameroonian health authorities announced that experts of traditional Chinese medicine will be providing lectures on TCM, Eunice Nchang was among the first to arrive at the lecture hall. A medical worker with extensive experience in the treatment of injury, disease and disorders through physical methods, Nchang had witnessed the palpable results of TCM on her patients. Five years ago, a middle-aged woman with a back injury made a three-hour journey to Gynaeco-Obstetric and Paediatric Hospital in the capital Yaounde where Nchang works, to get treatment and she was referred…
-
Interview: Behind Olympic golds, traditional Chinese medicine plays a role
As Gu Ailing won a historical gold in the women’s Freeski Big Air at the Beijing 2022 Winter Olympic Games, a doctor of the Chinese team revealed the role that Traditional Chinese Medicine (TCM) plays in treating China’s Olympians. Zhu Jiangwei, a physician at the Sichuan Province Orthopedic Hospital, worked for China’s national freeski big air and snowboard slopestyle team between October 2021 and January this year. Along with the team, Zhu traveled to Austria, Switzerland, the United States and other countries, providing medical care to members of the team,…
-
Traditional Chinese medicine enters global stage
The Traditional Chinese Medicine (TCM) practices of acupuncture and moxibustion have been inscribed ion UNESCO’s Representative List of Intangible Cultural Heritage of Humanity since 2010.
-
China to establish national demonstration zones for TCM reform
Seven provincial-level regions in China have been granted approval for establishing national demonstration zones for the comprehensive reform of traditional Chinese medicine (TCM), the national TCM authority said on Friday. Shanghai, Zhejiang, Jiangxi, Shandong, Hunan, Guangdong and Sichuan are among the first batch in the country to receive such approval, according to the National Administration of TCM. The demonstration zones are aimed to pilot reforms in the service model, industrial development and quality supervision of TCM, among other aspects.
-
Part 1: Can Medication Help Mesothelioma Survivors With Anxiety?
As a psychotherapist specializing in working with mesothelioma patients, I speak with many survivors who experience anxiety and seek relief. Symptoms of anxiety and depression top the list of mental health issues that mesothelioma patients, and cancer patients in general, cope with throughout treatment.
-
China composes TCM therapy for patients with Omicron by studying their syndromes
A pharmacist fulfills a Chinese Traditional Medicine (TCM) prescription at Gansu Provincial Hospital of Traditional Chinese Medicine (TCM) in Lanzhou, northwest China’s Gansu Province, Oct. 23, 2021. (Xinhua) China will study traditional Chinese medicine (TCM) therapy to treat patients with the Omicron strain, experts with the National Administration of Traditional Chinese Medicine said on Thursday. Practitioner said TCM could play a bigger role in COVID-19 treatment if patients with the Omicron strain showed mild symptoms or none, as studies showed, as TCM has proven effective in treating COVID-19 patients through…
-
Traditional Chinese medicine is effective for recurrent respiratory infections in children: Study
Indeed, the adoption of YPF in RRTI treatment could benefit thousands of children worldwide, and especially those from lower socioeconomic backgrounds. YPF could be one among a line of TCMs gaining worldwide recognition for their treatment benefits, crossing out the “pseudo” while focusing on the “science.”
